KLRB1 (coding for CD161) gene expression shows a positive association with favorable outcome in non-small-cell lung cancer, independently of the size of T and B cell infiltrates, making CD161-expressing CD4+ T cells ideal candidates for anti-tumor recall responses30. This evidence concerns the gene CD4 and non-small cell lung carcinoma.